SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001062993-24-002200
Filing Date
2024-02-07
Accepted
2024-02-07 13:53:30
Documents
1
Group Members
BOAZ R. WEINSTEINSABA CAPITAL MANAGEMENT GP, LLC

Document Format Files

Seq Description Document Type Size
1 FORM SC 13G/A formsc13ga.htm SC 13G/A 50687
  Complete submission text file 0001062993-24-002200.txt   52563
Mailing Address 405 LEXINGTON AVENUE 58TH FLOOR NEW YORK NY 10174
Business Address 405 LEXINGTON AVENUE 58TH FLOOR NEW YORK NY 10174 212-542-4635
Saba Capital Management, L.P. (Filed by) CIK: 0001510281 (see all company filings)

IRS No.: 800361690 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Subject) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92863 | Film No.: 24603656
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)